Submitted by Anonymous (not verified) on 11 May 2026 - 9:50
Human medicines European public assessment report (EPAR): Ojemda, tovorafenib, Date of authorisation: 20/04/2026, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ojemda, tovorafenib, Date of authorisation: 20/04/2026, Status: Authorised